Skip to main content

Rani Therapeutics Holdings, Inc.

RANI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001856725

In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Rani Therapeutics Holdings, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of RANI: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders3142+11
Shares5.91M3.82M−2.09M (−35.4%)
Value$12.8M$5.23M−$7.53M (−59.0%)

New holders (16)

Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to RANI in Q4 2024
InstitutionSharesValue% of portfolio
Two Sigma Investments, LP291,381$399.2K0.00%
Kestra Private Wealth Services, LLC119,620$163.9K0.00%
Two Sigma Advisers, LP110,163$150.9K0.00%
Insigneo Advisory Services, LLC47,500$65.1K0.01%
Virtu Financial LLC45,404$62.0K0.00%
Janney Montgomery Scott LLC27,200$37.0K0.00%
Ground Swell Capital, LLC17,153$23.5K0.05%
XTX Topco Ltd12,890$17.7K0.00%
RSM US Wealth Management LLC11,813$16.4K0.00%
Squarepoint Ops LLC10,863$14.9K0.00%
Commonwealth Equity Services, LLC10,409$14.0K0.00%
SBI Securities Co., Ltd.7,099$9.73K0.00%
R Squared Ltd2,170$2.97K0.00%
Advisor Group Holdings, Inc.1,500$2.06K0.00%
AlphaMark Advisors, LLC500$1.00K0.00%
Stonebridge Financial Group, LLC100$1370.00%

Sold out (5)

Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of RANI in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Armistice Capital, LLC2,574,000$5.56M
Renaissance Technologies LLC33,199$71.7K
Millennium Management LLC11,447$24.7K
Simplex Trading, LLC2,835$6.00K
Tower Research Capital LLC (TRC)1,721$3.72K